Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.

ABSTRACT:

Background

There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.

Objective

Develop evidence-based, rapid, living guidelines intended to support patients, clinicians, and other healthcare professionals in their decisions about treatment and management of patients with COVID-19.

Methods

In March 2020, the Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise to regularly review the evidence and make recommendations about the treatment and management of persons with COVID-19. The process used a living guide

SUBMITTER: Bhimraj A 

PROVIDER: S-EPMC9494372 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature